Abstract:Inadequate 24-hour blood pressure control could cause complications, especially in high-risk hypertensive individuals. Hence, it is recommended that the targeted blood pressure levels be maintained round the clock. This prospective, observational study assessed the 24-hour ambulatory blood pressure (ABP) control with 8-week amlodipine therapy 5/10 mg/day in patients with hypertension. Adult patients (62 m, 42 f) with mild-to-moderate essential hypertension received oral amlodipine 5 mg/day (n = 68) or 10 mg/day (n = 36) for 8 weeks. The study was approved by the independent ethics committee and informed consent was obtained from all participants. Primary outcome was change at 8 weeks from baseline in mean 24-hr ABP (systolic and diastolic), and secondary outcomes were change from baseline in mean morning, daytime, night-time, and last 6-hr dosing interval ABP. A repeat measures analysis of covariance (ANCOVA) was done for changes in ABP over 8 weeks, with age, gender, BMI and associated comorbidities as covariates. Nocturnal dippers were assessed as those greater than or equal to 10% reduction in ABP at 8 weeks. Sub-groups were created based on age, duration of hypertension, occupation, baseline BMI and amlodipine dose. Safety was evaluated based on clinical adverse events and 12-lead electrocardiogram. Of the 104 patients from 2 study centers, 49 completed 8-weeks therapy and were included for per-protocol analysis. Significant reductions in the mean 24-hr blood pressure were seen for both SBP and DBP (figure 1). The mean 24-hr. reduction was -10.82 and -6.25 mmHg with 5 mg amlodipine and -19.81 and -11.19 mmHg with 10 mg amlodipine for SBP and DBP respectively (p < 0.0001). The mean morning, daytime, night-time, and last 6-hr reductions in SBP were -14.06, -18.63, -20.42, and -13.51 respectively (p < 0.0001), and DBP reductions were -7.78, -10.27, -11.07, and -6.44 respectively (p < 0.0001). Significant reduction in ABP was seen in all sub-groups (p < 0.0001). Greater reduction in SBP and DBP were observed in patients with stage-2 hypertension. At baseline, there were 30 (61.2%) non-dippers which decreased to 18 (36.7%) at 8 weeks. At the end of the study, 40% of non-dippers were converted to dippers by Amlodipine, whereas none of the dippers were converted to non-dippers. No adverse effects were reported. Amlodipine significantly reduces the 24-hr. mean morning, daytime, night-time, and last 6-hr. ABP and converted non dippers to dippers in adult patients with mild to moderate essential hypertension. The Study highlights the consistent effects of amlodipine on both quantity and quality of 24 hours BP control which is important for associated CV risk reduction.

Effects of Amlodipine and Valsartan on Blood Pressure Variability and Pulse Wave Velocity in Hypertensive Patients.

Effect of Valsartan on the Level of Vwf in Patients with Hypertension and Metabolic Syndrome

Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia

Effects of Amlodipine and Other Classes of Antihypertensive Drugs on Long-Term Blood Pressure Variability: Evidence from Randomized Controlled Trials.

A5504 Comparison of the Effects of Valsartan and Amlodipine on the Characteristics of Ambulatory Blood Pressure in Hypertensive Patients

The Effects Between Single Long-Acting and Combination of Short-Acting Antihypertensive Drugs Treatment on Visit-to-visit Systolic Blood Pressure Variability

Effects of the Valsartan/amlodipine Combination and Nifedipine Gastrointestinal Therapeutic System Monotherapy on Brachial Pulse Pressure and Radial Augmentation Index in Hypertensive Patients

E0599 the Impact of Valsartan on Arterial Stiffness in Patients with Coronary Heart Disease and Hypertension

Effect of levamlodipine besylate on vascular function in patients with mild-to-moderate hypertension

Comparison the Effects of Antihypertensive Agents on Arterial Structure and Function with Non-Dependent Blood Pressure Reduction

A Randomized Multicenter Study on Ambulatory Blood Pressure and Arterial Stiffness in Patients Treated with Valsartan/amlodipine or Nifedipine GITS.

The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension

Amlodipine/Valsartan 5/160 Mg Versus Valsartan 160 Mg In Chinese Hypertensives

Effects of monolithic compound preparations based on angiotensin II receptor antagonist on the prognosis of patients with hypertension

Effects of Amlodipine Plus Telmisartan or Amlodipine Plus Amiroride Regimen on Blood Pressure Control in Hypertensive Patients:Preliminary Report of Chinese Hypertension Intervention Efficacy (Chief)trial

Effect of valsartan on chronotropic incompetence in hypertensive patients complicated with type 2 diabetes mellitus

Synergistic Effects of Atenolol and Amlodipine for Lowering and Stabilizing Blood Pressure in 2K1C Renovascular Hypertensive Rats.

PS-C10-9: EFFECTIVENESS OF AMLODIPINE ON 24-HOUR AMBULATORY BLOOD PRESSURE IN ADULT PATIENTS WITH MILD-MODERATE ESSENTIAL HYPERTENSION: A MULTICENTRE OBSERVATIONAL, REAL-WORLD STUDY

Effects of Fosinopril Vs Amlodipine on Brachial Ankle Pulse Wave Velocity and Pulse Pressure in Patients of Primary Hypertension

The Effectiveness and Safety of L-amlodipine Besylate for Blood Pressure Control in Patients with Mild to Moderate Essential Hypertension

Effects of Telmisartan on Mild to Moderate Essential Hypertension Assessed by 48 H Ambulatory Blood Pressure Monitoring